To our knowledge, this study is the first to report on clinical observations of phosphate diabetes in acute hepatitis, as attested by excessive serum FGF23 levels together with hepatic overexpression of FGF23, as compared with findings in normal hepatic tissue or liver cirrhosis. This evidence concerns the gene FGF23 and Acute hepatitis.